<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOHNS</journal-id><journal-title-group><journal-title>International Journal of Otolaryngology and Head &amp; Neck Surgery</journal-title></journal-title-group><issn pub-type="epub">2168-5452</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijohns.2018.76033</article-id><article-id pub-id-type="publisher-id">IJOHNS-88362</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Hearing Outcome in Stapes Surgery Using Various Biomaterial Prostheses
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sasindran</surname><given-names>Vivek</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>N.</surname><given-names>K. Febin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mathew</surname><given-names>Nidhi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>B.</surname><given-names>Harikrishan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Otorhinolaryngology and Head &amp;amp; Neck Surgery, Pushpagiri Medical College, Tiruvalla, India</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>11</month><year>2018</year></pub-date><volume>07</volume><issue>06</issue><fpage>330</fpage><lpage>343</lpage><history><date date-type="received"><day>10,</day>	<month>August</month>	<year>2018</year></date><date date-type="rev-recd"><day>6,</day>	<month>November</month>	<year>2018</year>	</date><date date-type="accepted"><day>9,</day>	<month>November</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Aims: To assess the hearing outcome in patients who have undergone stapes surgery using polytetrafluoroethylene (PTFE) and Titanium prosthesis at 1 and 3 months post operatively. 
  Material &amp; Methods: Research design: Prospective study. Setting: ENT department, Pushpagiri Medical College. Study population: All age groups with clinical diagnosis of otosclerosis and air-bone gap more than 15 dB irrespective of sex difference. Patients with Meniere’s disease are excluded. Method: A prospective study was conducted for a period of one and a half years from January 2014 to July 2015 to find out the hearing outcome of stapes surgery in patients with otosclerosis using polytetrafluoroethylene (PTFE) and Titanium prostheses, attending our outpatient department.
   Results: In this study, 84.21% of ears with polytetrafluoroethylene (PTFE) and 81.81% of ears with titanium were able to achieve good results in terms of Air-Bone gap (ABG) closure (ABG &lt; 20 dB). The average post op hearing following stapes surgery at 3 months improved to near normal levels of 34.12 dB &#177; 8.95 with an average hearing gain of 19.19 dB with PTFE prosthesis and 30.86 dB &#177; 5.47 with an average hearing gain of 21.2 dB with titanium which were significant. 
  Conclusion: Stapes surgery is the surgical procedure of choice for otosclerosis. In our study, a significant hearing improvement was seen in majority of cases. None of the factors considered relevant for the success of stapes surgery like age, sex, type of prosthesis appeared to affect the post-operative hearing significantly. Hence stapes surgery can be effectively used to improve hearing in otosclerosis.
 
</p></abstract><kwd-group><kwd>Otosclerosis</kwd><kwd> PTFE and Titanium</kwd><kwd> AC Threshold Gain</kwd><kwd> AB Gap</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Otosclerosis is the most common cause of progressive conductive hearing loss in adults. It is more common in females with 2:1 female to male ratio. The age of onset is usually third decade of life. The hearing loss is bilateral in 70% of cases. Otosclerosis is transmitted in an autosomal-dominant fashion with variable penetrance.</p><p>Otosclerosis is a localized hereditary disorder affecting endochondral bone of the otic capsule that is characterized by disordered resorption and deposition of bone. It begins as spongification of the bone of the otic capsule. It may cause conductive hearing loss, a mixed hearing loss or occasionally a purely sensorineural hearing loss.</p><p>In 1860, Toynbee [<xref ref-type="bibr" rid="scirp.88362-ref1">1</xref>] first described the condition causing a hearing loss by fixation of the stapes. In 1893, Politzer [<xref ref-type="bibr" rid="scirp.88362-ref2">2</xref>] referred to the fixation of the stapes asotosclerosis. Siebenmann [<xref ref-type="bibr" rid="scirp.88362-ref3">3</xref>] revealed on microscopic examination that the lesion seemed to begin as spongification of the bone and termed the process otospongiosis.</p><p>The main complaint of the patient will be progressive hearing loss. If it involves stapes, hearing loss will be conductive; the commonest site of involvement being anterior crura. The disease progresses to involve the entire footplate. It may progress anteriorly to involve the cochlea leading to sensorineural hearing loss as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Otosclerosis is an autosomal dominant disease with variable penetrance and expression. Women are more affected (2:1). Age of onset is late teens or early 20s, but may not occur until the 30s or early 40s. At the House Ear Clinic, the youngest patient with surgically confirmed otosclerosis was 6 years old [<xref ref-type="bibr" rid="scirp.88362-ref4">4</xref>] . It is aggravated in pregnancy and many present with symptoms after their first pregnancy. Clinicalotosclerosis is rare in blacks, Asians, and Native Americans [<xref ref-type="bibr" rid="scirp.88362-ref5">5</xref>] - [<xref ref-type="bibr" rid="scirp.88362-ref11">11</xref>] .</p><p>Occasionally, the lesion may involve only the cochlea, causing an isolated sensorineural hearing loss. Sometimes the entire cochlea is surrounded by otosclerosis, causing total deafness. In the United States, 20 of the first 57 patients to have a cochlear implant were made deaf by otosclerosis [<xref ref-type="bibr" rid="scirp.88362-ref12">12</xref>] .</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Type of Study and Source of Data</title><p>A prospective study was conducted for a period of one and a half years from January 2014 to July 2015 to find out the hearing outcome of stapes surgery in patients with otosclerosis using PTFE and Titanium prostheses, attending ENT OPD at Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala.</p></sec><sec id="s2_2"><title>2.2. Inclusion Criteria</title><p>Patients presenting with history, clinical features and audiological findings of otosclerosis with air-bone gap of more than 15dB with conductive hearing loss andintact tympanic membrane who underwent stapes surgery with various biomaterial prostheses. Patients of both sex, all age groups, patients who underwent bilateral and revision surgeries come under the study.</p></sec><sec id="s2_3"><title>2.3. Exclusion Criteria</title><p>Patients with Meniere’s disease are excluded from the study.</p></sec><sec id="s2_4"><title>2.4. Method of Data Collection</title><p>All patients with clinical diagnosis of otosclerosis with air-bone gap of more than 15 dB across 500 Hz, 1000 Hz, and 2000 Hz in whom stapes surgery was planned and were willing to undergo surgery were selected for surgery. A total of 30 ears (28 patients where two patients underwent bilateral surgery) had undergone stapes surgery during the study period. A complete history, ENT examination and appropriate investigations [Pure Tone Audiogram, Speech Audiometry, Tympanometry] were done to arrive at the correct diagnosis.</p></sec></sec><sec id="s3"><title>3. Results</title><p>A total of 30 ears (28 patients where two patients underwent bilateral surgery) of otosclerosis underwent stapes surgery with either polytetrafluroethylene (PTFE) or Titanium in Pushpagiri Medical College from January 2014 to July 2015. All the patients were available for PTA follow up at 1 month and 3 months after surgery and they were compared with pre operative PTA value. All the cases were operated by a single surgeon. The data were analyzed under the following headings:</p><p>1) Patient factors;</p><p>2) Surgical factors;</p><p>3) Results.</p><sec id="s3_1"><title>3.1. Patient Factors</title><sec id="s3_1_1"><title>3.1.1. Age Distribution (Number of Patients)</title><p>Out of the, 53.57% of the patients were between the age group of 21 to 40 years. There was only one patient above 70 years.</p></sec><sec id="s3_1_2"><title>3.1.2. Sex Distribution (Number of Patients)</title><p>In our series of 28 patients (30 ears since two patients underwent bilateral surgery), 14 were males and 14 were females. The male to female ratio was 1:1.</p></sec></sec><sec id="s3_2"><title>3.2. Surgical Factors</title>Type of Prosthesis (Number of Ears Operated)<p>Out of 30 ears (28 patients where two patients underwent bilateral surgery), 19ears underwent stapes surgery with PTFE biomaterial prosthesis, 11 underwent surgery with titanium prosthesis.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows, out of 28 patients (30 ears since two patients underwent bilateral surgery), 2 patients underwent bilateral stapes surgery and 26 patients underwent unilateral surgery. So there were 7.17% patients of bilateral and 92.86% patients of unilateral stapes surgery.</p><p><xref ref-type="table" rid="table2">Table 2</xref> shows, one patient had to undergo revision surgery out of 28 patients (30 ears since two patients underwent bilateral surgery). It was due to dislocation of prosthesis and was operated second time 3 months after primary surgery.</p></sec><sec id="s3_3"><title>3.3. Results</title><p>TITANIUM: The average pre-op hearing loss was (AC) was 52.06 dB &#177; 7.70. The average post op hearing (AC) at 1 month follow up was 39.33 dB &#177; 6.85 with an average hearing gain of 12.73 dB which was significant. The average post op hearing (AC) at 3months improved to 30.86 dB &#177; 5.47 with an average hearing gain of 21.2 dB which was also significant as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>PTFE: The average pre-op hearing loss was (AC) was 53.31 dB &#177; 7.71. The average post op hearing (AC) at 1month follow up was 41.75 dB &#177; 7.53 with an average hearing gain of 11.56 dB which was significant. The average post op hearing (AC) at 3 months improved to 34.12 dB &#177; 8.95 with an average hearing gain of 19.19 dB which was also significant as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>TITANIUM: -In our study of 30 ears operated (28 patients where two patients underwent bilateral surgery), based on improvement of AB gap (according to Wehr’s classification), 8 ears had excellent improvement at 3 months post operatively, 1 ear had good improvement, 2 ears fair improvement and no failure cases by the end of 3 months post op as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>PTFE: -In our study, 12 ears had excellent improvement at 3 months post operatively, 4 ears had good improvement, 1 ear fair improvement and 2 failure cases by the end of 3 months post op as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>TITANIUM: -The average pre op ABG was 28.67 dB &#177; 4.60. The average post op ABG at 1 month post op follow up was 17.21 dB &#177; 7.37 with an average closure of 11.46 dB which was found to be significant. The average post op ABG at 3 months post op follow up was 12.36 dB &#177; 5.29 with an average closure of 16.31 dB which was found to be significant as shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p>PTFE: -The average pre op ABG for PTFE prosthesis was 29.26 dB &#177; 8.73. The average post op ABG at 1 month post op follow up was 18.26 dB &#177; 7.14 with an average closure of 11 dB which was found to be significant. The average post op ABG at 3 months post op follow up was 14.2 dB &#177; 8.62 with an average closure of 15.06 dB which was found to be significant as shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows the average AC threshold post op at 1 month using PTFE was 41.75 &#177; 7.53. The average AC threshold post op at 1 month using titanium was 39.33 &#177; 6.85. The comparative study was not statistically significant. The average AC threshold post op at 3 months using PTFE was 34.12 &#177; 8.95. The average AC threshold post op at 3 months using titanium was 30.86 &#177; 5.47. The comparative study was not statistically significant.</p><p>The average ABG threshold post op at 1 month using PTFE was 18.26 &#177; 7.14. The average ABG threshold post op at 1 month using titanium was 17.21 &#177; 7.37. The comparable study was not statistically significant.</p><p>The average ABG threshold post op at 3 month using PTFE was 14.2 &#177; 8.62. The average ABG threshold post op at 3 month using titanium was 12.36 &#177; 5.29. The comparative study was not statistically significant as shown in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>84.21% ears with PTFE has good to excellent improvement (less than 20 dB) in ABG at 3 months post operatively. 81.81% ears with titanium has good to excellent improvement (less than 20 dB) in ABG at 3 months post operatively as described in <xref ref-type="table" rid="table5">Table 5</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Number of unilateral and bilateral cases (number of patients)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Total no. of patients operated</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Bilateral</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7.17</td></tr><tr><td align="center" valign="middle" >Unilateral</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >92.86</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Revision cases (number of ears operated)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Total No. of ears operated</th><th align="center" valign="middle" >No. of revision cases</th><th align="center" valign="middle" >Percentage of revision cases</th></tr></thead><tr><td align="center" valign="middle" >30</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.33</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of AC threshold post op 1 month &amp; 3 months between PTFE and Titanium</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="13"  >Post-Op 1 month</th></tr></thead><tr><td align="center" valign="middle"  colspan="7"  >PTFE</td><td align="center" valign="middle"  colspan="6"  >Titanium</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="3"  >Mean (dB)</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle"  colspan="2"  >P-value</td><td align="center" valign="middle"  colspan="3"  >Mean (dB)</td><td align="center" valign="middle"  colspan="2"  >SD</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >AC</td><td align="center" valign="middle"  colspan="3"  >41.75</td><td align="center" valign="middle" >7.53</td><td align="center" valign="middle"  colspan="2"  >0.603</td><td align="center" valign="middle"  colspan="3"  >39.33</td><td align="center" valign="middle"  colspan="2"  >6.85</td><td align="center" valign="middle" >0.595</td></tr><tr><td align="center" valign="middle"  colspan="13"  >Post-Op 3 month</td></tr><tr><td align="center" valign="middle"  colspan="8"  >PTFE</td><td align="center" valign="middle"  colspan="5"  >Titanium</td></tr><tr><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle"  colspan="3"  >SD</td><td align="center" valign="middle"  colspan="2"  >p-value</td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle"  colspan="2"  >SD</td><td align="center" valign="middle"  colspan="2"  >p-value</td></tr><tr><td align="center" valign="middle"  colspan="2"  >AC</td><td align="center" valign="middle" >34.12</td><td align="center" valign="middle"  colspan="3"  >8.95</td><td align="center" valign="middle"  colspan="2"  >0.385</td><td align="center" valign="middle" >30.86</td><td align="center" valign="middle"  colspan="2"  >5.47</td><td align="center" valign="middle"  colspan="2"  >0.326</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Comparison of ABG post op 1 month &amp; 3 months between PTFE and Titanium</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="7"  >Post -op 1 month</th></tr></thead><tr><td align="center" valign="middle"  colspan="4"  >PTFE</td><td align="center" valign="middle"  colspan="3"  >Titanium</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >AC</td><td align="center" valign="middle" >18.26</td><td align="center" valign="middle" >7.14</td><td align="center" valign="middle" >0.662</td><td align="center" valign="middle" >17.21</td><td align="center" valign="middle" >7.37</td><td align="center" valign="middle" >0.666</td></tr><tr><td align="center" valign="middle"  colspan="7"  >Post-op 3 month</td></tr><tr><td align="center" valign="middle"  colspan="4"  >PTFE</td><td align="center" valign="middle"  colspan="3"  >Titanium</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >Mean (dB)</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >AC</td><td align="center" valign="middle" >14.2</td><td align="center" valign="middle" >8.62</td><td align="center" valign="middle" >0.652</td><td align="center" valign="middle" >12.36</td><td align="center" valign="middle" >5.29</td><td align="center" valign="middle" >0.609</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Comparison of percentage of ears showing ABG post op betweenPTFE and Titanium prosthesis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >ABG</th><th align="center" valign="middle"  colspan="2"  >1 month</th><th align="center" valign="middle"  colspan="2"  >3 months</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >PTFE (%)</td><td align="center" valign="middle" >Titanium (%)</td><td align="center" valign="middle" >PTFE (%)</td><td align="center" valign="middle" >Titanium (%)</td></tr><tr><td align="center" valign="middle" >&lt;10 (excellent)</td><td align="center" valign="middle" >5.26</td><td align="center" valign="middle" >9.09</td><td align="center" valign="middle" >63.16</td><td align="center" valign="middle" >72.72</td></tr><tr><td align="center" valign="middle" >11 - 20 (good)</td><td align="center" valign="middle" >68.42</td><td align="center" valign="middle" >63.63</td><td align="center" valign="middle" >21.05</td><td align="center" valign="middle" >9.09</td></tr><tr><td align="center" valign="middle" >21 - 30 (fair)</td><td align="center" valign="middle" >15.79</td><td align="center" valign="middle" >18.18</td><td align="center" valign="middle" >5.26</td><td align="center" valign="middle" >18.18</td></tr><tr><td align="center" valign="middle" >&gt;31 (failure)</td><td align="center" valign="middle" >10.52</td><td align="center" valign="middle" >9.09</td><td align="center" valign="middle" >10.52</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>In the present study, 30 ears (28 patients where two patients underwent bilateral surgery) with otosclerosis underwent stapes surgery and were analyzed and followed up for post op improvement in hearing at 1 month and 3 months. Varioushost and surgical factors which could affect the surgical results were considered and analyzed.</p><p>The minimum age in our study group was 23 years and maximum age in the group was 73 years. The maximum number of patients was in the age group of 21 - 40 years (53.57%). Clinical otosclerosis is more frequent between the ages of 20 and 30 (Nager, 1969) [<xref ref-type="bibr" rid="scirp.88362-ref14">14</xref>] . Some cases become evident as early as six or seven, but the majority manifest between ages 15 and 35, with a few cases as late as 54 years old (Shambaugh, 1961). Average ageof onset has been reported to be 33 (Panama, 1987), 29 (Minnesota, 1978), 24 (Chile, 1987), and 23 (Brazil, 1987).</p><p>Age does not significantly affect the success rate of stapes surgery. Kulakova et al. [<xref ref-type="bibr" rid="scirp.88362-ref15">15</xref>] found that the surgical intervention on the stirrup bone for the treatment of otosclerosis in the patients above 65 years of age is a safe and efficacious method despite marked hearing impairment in this group of patients. Massey et al. [<xref ref-type="bibr" rid="scirp.88362-ref16">16</xref>] evaluated the outcomes of stapedectomy surgery for congenital stapes fixation and found that stapedectomy remains an effective method to achieve significant hearing improvement in the majority of patients for congenital fixation. Age is not a detriment to hearing gain and instead might result in better use of hearing aids in older adults, thus facilitating social hearing recovery [<xref ref-type="bibr" rid="scirp.88362-ref17">17</xref>] . In our study group, there was no patient in paediatric age group and there is one patient in geriatric age group. Therefore, it is not possible to correlate age as a significant success factor for surgery.</p><p>Univariate and multivariate analyses indicated that none of the pre-operative factors (piston type, age, sex, affected side, tinnitus, vertigo, and pre-operative hearing thresholds) affected hearing success significantly (all p &gt; 0.05).</p><p>In our series of 28 patients (30 ears since two patients underwent bilateral surgery), 14 patients were males and 14 were females. The male to female ratio was 1:1. The success of stapes surgery for otosclerosis is not dependent on sex of the patients [<xref ref-type="bibr" rid="scirp.88362-ref17">17</xref>] . The prevalence of otosclerosis is greater in women, with a 2:1 female-tomaledistribution [<xref ref-type="bibr" rid="scirp.88362-ref18">18</xref>] . The difference in the study arises due to random assignment.</p><p>Shabana et al. [<xref ref-type="bibr" rid="scirp.88362-ref19">19</xref>] conducted study using a 0.4-mm diameter Teflon platinumpiston and a 0.6-mm diameter PTFE piston. The postoperative air-bone gap, calculated as the difference between the postoperative air and bone conduction levels, was smaller in the 0.6 mm group for all frequencies except at 2000 Hz; the differences were statistically insignificant except at 4000 Hz. It was concluded that the 0.4 mm and the 0.6 mm PTFE prostheses produced the same hearing improvement in stapessurgery for otosclerosis. In our series of study, we used diameters of 0.4 mm PTFE prosthesis and 0.4 mm titanium prosthesis. There was no significant difference in the hearing outcome. The measurement of the piston is always described as a significant stage of the surgery, but its length is never clearly defined [<xref ref-type="bibr" rid="scirp.88362-ref20">20</xref>] .</p><p>The measurement of the length of the piston is very significant, and in our study, the majority of the pistons were cut at 4.75 mm which indicates an incus-footplate measurement of 4.25 mm. In our series of cases, we routinely measured the length of the pistons which were 4.25 - 4.75 mm long. In our series of study, the fenestra was sealed with gel foam.</p><p>In this study, the hearing improvement at 1 month and 3 months were evaluated. We used two types of prostheses, i.e. PTFE and Titanium. Here we are reporting short term hearing results because long term success of stapes surgery is largely dependent on factors outside the control of surgeon like patient follow-up rate, period of study. The short-term results are a more accurate reflection of the actualsurgical outcome.</p><p>In the study, the hearing outcome was analysed by comparing the pre op airconduction and post op air conduction threshold and air-bone gap at 1 month and 3 months and analysis is done for PTFE and Titanium prostheses separately and determining if there was significant improvement. The average pre-operative and post-operative AC threshold was calculated by taking the frequencies across 500 Hz, 1000 Hz and 2000 Hz. Air-bone gaps were calculated using air conduction and boneconduction thresholds at frequencies 500 Hz, 1000 Hz and 2000 Hz.</p><p>The average pre-op hearing loss in this study with titanium was (AC) was 52.06 dB &#177; 7.70. The average post op hearing (AC) at 1month follow up was 39.33 dB &#177; 6.85 with an average hearing gain of 12.73 dB which was significant. The average post op hearing (AC) at 3 months improved to 30.86 dB &#177; 5.47 with an average hearing gain of 21.2 dB which was also significant. This was similar to results of Boleas-Aquirre et al. [<xref ref-type="bibr" rid="scirp.88362-ref21">21</xref>] who reported the overall improvement in airconduction thresholds and pure-tone average air conduction for all frequencies after 1 year of surgery. Ataide et al. [<xref ref-type="bibr" rid="scirp.88362-ref20">20</xref>] did audiometric evaluation after stapedotomy with Fisch titanium prosthesis and showed improvement post operatively. The mean hearing gain was also reported by Boleas-Aquirre et al. [<xref ref-type="bibr" rid="scirp.88362-ref21">21</xref>] .</p><p>In our study of 30 ears operated, based on improvement of AB gap (according to Wehr’s Classification) among titanium prosthesis, 8 ears had excellent improvement at 3 months post operatively, 1 ear had good improvement, 2 ears fair improvement and no failure cases by the end of 3 months post op. Singh et al. [<xref ref-type="bibr" rid="scirp.88362-ref21">21</xref>] found out that the titanium soft clip stapes piston gives good results in cases of stapedotomy forotosclerosis. The soft clip design is a new development in the evolution of stapespiston prostheses. Surgical introduction, placement, and fixation are easier than the earlier design of clip piston.</p><p>The air-bone gap with titanium in the study of Boleas-Aguirre et al. [<xref ref-type="bibr" rid="scirp.88362-ref21">21</xref>] was significantly reduced 1 year after surgery and remained so at 4 years. Preoperative air-bonegap, 34.04 dB; at 1 year, 16.40 dB; at 4 years, 17.3 dB. In our study, the average pre op ABG with titanium was 28.67 dB &#177; 4.60. The average post op ABG was analysed at 1 month and post op follow up showed AB gap of 17.21 dB &#177; 7.37 with an average closure of 11.46 dB which was found to be significant. The average post op ABG at 3 months post op follow up was 12.36 dB &#177; 5.29 with an average closure of 16.31 dB which was found to be significant. Ataide et al. [<xref ref-type="bibr" rid="scirp.88362-ref22">22</xref>] found out that the mean low-frequency postoperative air-bone gap was 12.9 dB. Twenty-five (75.8%) patients had air-bone gaps of 10 dB and under; 32 (96.9%) patients had gaps of 20 dB and under; and all patients had gaps of 30 dB and under.</p><p>The average pre-op hearing loss with PTFE was (AC) was 53.31 dB &#177; 7.71. The average post op hearing (AC) at 1month follow up was 41.75 dB &#177; 7.53 with an average hearing gain of 11.56 dB which was significant. The average post op hearing (AC) at 3 months improved to 34.12 dB &#177; 8.95 with an average hearing gain of 19.19 dB which was also significant. Ahmed et al. [<xref ref-type="bibr" rid="scirp.88362-ref23">23</xref>] assessed hearing improvement after stapedotomy for otosclerosis using PTFE loop prosthesis. Pre-operative audiograms showed conductive deafness. Carhart’s notch was present in 33.3% cases. Tympanogram revealed loss of stapedial reflex. Postoperatively good hearing improvement was seen in 56.7%.</p><p>In our study of 30 ears operated, 12 ears had excellent improvement at 3 months post operatively, 4 ears had good improvement, 1 ear fair improvement and 2 failure cases by the end of 3 months post op. In the study conducted by Ahmed et al. [<xref ref-type="bibr" rid="scirp.88362-ref24">24</xref>] , postoperatively good hearing improvement was seen in 56.7%, fair improvement in 30% and poor results in 10% cases. One patient developed dead ear.</p><p>The average pre op ABG with PTFE prosthesis was 29.26 dB &#177; 8.73. The average post op ABG at 1 month post op follow up was 18.26 dB &#177; 7.14 with an average closure of 11 dB which was found to be significant. The average post op ABG at 3 months post op follow up was 14.2 dB &#177; 8.62 with an average closure of 15.06 dB which was found to be significant. Dall’igna et al. [<xref ref-type="bibr" rid="scirp.88362-ref25">25</xref>] in his study found out that bone-air gap reduced in an average value of 21.90 dB (p &lt; 0.05) after the surgery in the group that received the PTFE prosthesis and gain in SRT was of 22.33 and the air-bone gap was below 20 dB in 80.6%</p><p>All patients in the study had better improvement at 3 months post op when compared to 1 month post op air conduction and air-bone gap closure except in one case where there was displacement of prosthesis 3 months after stapes surgery and was operated again. Hearing improves once the swelling subsides, the slight bleeding behind the ear drum dries up and the packing is absorbed or removed, usually within two weeks. Hearing continues to get better over the next three months.</p><p>There was improvement in bone conduction in 27 out of 30 ears in the study after undergoing stapes surgery. Improvement was more in patients whose bone conduction preoperatively was equal to or more than 30 dB. This is similar to studies of Morshed et al. [<xref ref-type="bibr" rid="scirp.88362-ref26">26</xref>] where he found out there was significant improvement of AC obtained after stapedectomy. There was also significant improvement of BC at all the frequencies examined of 6 - 12 dB and it depended on BC threshold before surgery. In the group of 37 patients with BC threshold before surgery &gt; or = 30 dB, a significant improvement of BC after stapedectomy developed. In the group of 14 patients with BC threshold before surgery &lt; 30 dB, the change of BC after stapedectomy was not significant. Successful stapedectomy improves bone conduction. It means that inpatients with otosclerosis, there is a reversible BC pseudo hearing loss and it is related to BC threshold before the operation.</p><p>Out of 30 ears (28 patients), 2 patients underwent bilateral surgery for otosclerosis. The typical age of onset of noticeable hearing loss is in the third decade of life, and hearing loss is bilateral in 70% of cases [<xref ref-type="bibr" rid="scirp.88362-ref18">18</xref>] .</p><p>1 ear out of 30 ears (total of 28 patients where two patients underwent bilateral surgery) underwent revision surgery 3 months after primary surgery with PTFE prosthesis due to dislocation of prosthesis. The pre op air conduction threshold was 53.3 dB. It improved to 48.3 dB 1 month after surgery. But the hearing decreased 3 months after surgery to 60 dB. The air bone gap pre operatively was 21.7 dB. It improved to ABG of 20.3 dB 1 month after surgery. The ABG became 36.7 dB 3 months after surgery. This was due to dislocation of PTFE prosthesis. Skrivan et al. [<xref ref-type="bibr" rid="scirp.88362-ref27">27</xref>] reported the reasons of the recurrent or persisting hearing loss after previous stapessurgery indicated for otosclerosis. The main reason of the failed surgery was adhesions and dislocation of the prosthesis. The mean postoperative air-bone gap was 12.0 dB. A mean postoperative air-bone gap closure within 10 dB occurred in 24 cases (55.8%), between 11 - 20 dB occurred in 11 cases (25.6%) and above 20 dB in 8 cases (18.6%).</p><p>On comparing hearing outcome with PTFE and titanium, 72.72% of ears (8 out of 11) with titanium prosthesis had excellent improvement in ABG at 3 months after surgery. There were zero cases with ABG more than 31 dB whereas 63.16% of ears (12 out of 19) with PTFE prosthesis had excellent improvement in ABG at 3 months after surgery whereas ABG more than 31 dB was seen in 10.52% cases (2 out of 19). So, 84.21% ears with PTFE attained ABG less than 20 dB; it was 81.81% ears with titanium who attained ABG less than 20 dB. Thus it can be concluded that the result with respect to ABG between the two prosthesis were comparable and produced similar results. Similar results were seen with studies conducted by Massey et al. [<xref ref-type="bibr" rid="scirp.88362-ref28">28</xref>] where the study group was comprised of 35 titanium and 183 PTFE prostheses. Closure of the air-bone gap to less than 20 dB was achieved in 86% of the ears with PTFE prosthesis compared with 71% of those with titanium prostheses. Other studies included were by Rajesh et al. [<xref ref-type="bibr" rid="scirp.88362-ref29">29</xref>] where postoperative ABG of 20 dB or less was seen in 96% in both groups.</p><p>The average AC threshold post op at 1 month using PTFE was 41.75 &#177; 7.53. The average AC threshold post op at 1 month using titanium was 39.33 &#177; 6.85. The comparative study was not statistically significant. The average AC threshold post opat 3 month using PTFE was 34.12 &#177; 8.95. The average AC threshold post op at 3 month using titanium was 30.86 &#177; 5.47. The comparative study was also not statistically significant.</p><p>The average ABG threshold post op at 1 month using PTFE was 18.26 &#177; 17.14. The average ABG threshold post op at 1 month using titanium was 17.21 &#177; 7.37. The comparative study was not statistically significant. The average ABG threshold post op at 3 month using PTFE was 14.2 &#177; 8.62 which was not statistically significant. The average ABG threshold post op at 3 month using titanium was 12.36 &#177; 5.29 which was also not statistically significant. This was similar to studies of Rajesh et al. [<xref ref-type="bibr" rid="scirp.88362-ref29">29</xref>] where the mean postoperative ABG was 8.2 dB and 11.5 dB for PTFE and Titanium group respectively.</p><sec id="s4_1"><title>4.1. Alternative Treatment</title><sec id="s4_1_1"><title>4.1.1. Hearing Aids</title><p>All patients with conductive hearing loss caused by otosclerosis may use hearing aids as an alternative to surgery. If the patient has a significant sensorineural component to the hearing loss, a hearing aid may be required even after successful stapedectomy. A patient with far advanced otosclerosis requires a hearing aid at all times. It may take 4months before these patients can tolerate and benefit from the hearing aid.</p></sec><sec id="s4_1_2"><title>4.1.2. Fluoride Therapy</title><p>Injury to the inner ear is believed to occur as a result of the spread of proteolytic enzymes to the inner ear fluids from an active otospongiotic focus, with resultant injury to the organ of Corti and spiral ligament [<xref ref-type="bibr" rid="scirp.88362-ref30">30</xref>] . In patients with evidence of progressive sensorineural hearing loss, fluoride therapy has been shown to reduce the progression of hearing loss due to the conversion of the active otospongiotic lesion to a more stable otosclerotic lesion [<xref ref-type="bibr" rid="scirp.88362-ref30">30</xref>] . Patients are typically treated with Florical8 mg three times per day until hearing loss stabilizes.</p></sec></sec></sec><sec id="s5"><title>5. Conclusions</title><p>The main objective of this study is to assess the hearing outcome in stapessurgery using PTFE and titanium prostheses at 1 month and 3-month post operatively. The post operative AC threshold gain and ABG were taken as the two variables used to determine the hearing outcomes. The AC threshold improved post operatively in 95% ears with PTFE and 100% ears with titanium. The main cause for failure is dislocation of prosthesis which was encountered in one of the ears in the study with PTFE. The ABG attained post operatively at 3 months to less than 20 dB was in 84.21% ears of PTFE and 81.81% ears of titanium.</p><p>The bone conduction improved post operatively in 90% of ears which was more with ears with pre-op bone conduction threshold more than or equal to 30 dB. The comparison of hearing outcome in stapes surgery using PTFE and titanium were not significant statistically. Both prostheses produced similar and comparable results and it cannot be concluded one prosthesis is better than the other since ours is a small case series and the study is for shorter duration of time. It may require a larger case series and longer duration of time to find out if there is significant difference between the two prostheses. So PTFE and titanium can be equally suggested for patients in stapes surgery. In our study, we have analysed the hearing outcomes in stapes surgery using PTFE and titanium prostheses. Hence it is concluded that stapes surgery can be effectively used to improve hearing in otosclerosis irrespective of the prosthesis used.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Vivek, S., Febin, N.K., Nidhi, M. and Harikrishan, B. (2018) Hearing Outcome in Stapes Surgery Using Various Biomaterial Prostheses. International Journal of Otolaryngology and Head &amp; Neck Surgery, 7, 330-343. https://doi.org/10.4236/ijohns.2018.76033</p></sec></body><back><ref-list><title>References</title><ref id="scirp.88362-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Toynbee, J. (1860) Diseases of the Ear. Blanchard &amp; Lea, Philadelphia.</mixed-citation></ref><ref id="scirp.88362-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mudry, A. (2006) Adam Politzer (1835-1920) and the Description of Otosclerosis. Otology &amp; Neurotology, 27, 276-281. https://doi.org/10.1097/01.mao.0000187050.04286.80</mixed-citation></ref><ref id="scirp.88362-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ruedi, L. (1968) Friedrich Siebenmann: 1852-1928. Archives of Otolaryngology, 88, 213-217. https://doi.org/10.1001/archotol.1968.00770010215027</mixed-citation></ref><ref id="scirp.88362-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">House, J.W., Sheehy, J.L. and Antunez, J.C. (1980) Stapedectomy in Children. Laryngoscope, 90, 1804-1809. https://doi.org/10.1288/00005537-198011000-00007</mixed-citation></ref><ref id="scirp.88362-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Altmann, F., Glasgold, A. and Macduff, J.P. (1967) The Incidence of Otosclerosis as Related Torace and Sex. Annals of Otology, Rhinology &amp; Laryngology, 76, 377-392. https://doi.org/10.1177/000348946707600207</mixed-citation></ref><ref id="scirp.88362-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Friedmann, I. (1974) Pathology of the Ear. Blackwell Scientific Publications, Oxford.</mixed-citation></ref><ref id="scirp.88362-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Guild, S.R. (1944) Histologic Otosclerosis. Annals of Otology, Rhinology &amp; Laryngology, 53, 246.</mixed-citation></ref><ref id="scirp.88362-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Levin, G., Fabian, P. and Stahle, J. (1988) Incidence of Otosclerosis. American Journal of Otolaryngology, 9, 299-301.</mixed-citation></ref><ref id="scirp.88362-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Nager, G.T. (1969) Histopathology of Otosclerosis. Archives of Otolaryngology, 89, 341-363. https://doi.org/10.1001/archotol.1969.00770020343022</mixed-citation></ref><ref id="scirp.88362-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Schuknecht, H.F. (1966) Sensorineural Deafness in Otosclerosis. Annals of Otology, Rhinology &amp; Laryngology, 75, 418. https://doi.org/10.1177/000348946607500211</mixed-citation></ref><ref id="scirp.88362-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Tato, J.M. and Tato Jr., J.M. (1967) Otosclerosis and Races. Annals of Otology, Rhinology &amp; Laryngology, 76, 1018-1025. https://doi.org/10.1177/000348946707600512</mixed-citation></ref><ref id="scirp.88362-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Berliner, K.I. and House, W.F. (1982) The Cochlear Implant Program: An Overview. Annals of Otology, Rhinology &amp; Laryngology, 91, 11-14.</mixed-citation></ref><ref id="scirp.88362-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Otosclerosis. Tampa Bay Hearing. https://www.tampabayhearing.com/ear-education/auditory-education/otosclerosis/</mixed-citation></ref><ref id="scirp.88362-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goycoolea</surname><given-names> M.V. </given-names></name>,<etal>et al</etal>. (<year>1991</year>)<article-title>Otosclerosis</article-title><source> Otology and Neuro-Otology</source><volume> 237</volume>,<fpage> 1489</fpage>-<lpage>1491</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.88362-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Kulakova, L.A., Poliakova, E.P., Bodrova, I.V. and Lopatin, A.S. (2014) The Results of the Surgical Treatment of Otosclerosis in the Elderly Subjects. Vestnik Otorinolaringologii, 3, 17-19.</mixed-citation></ref><ref id="scirp.88362-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Massey, B.L., Hillman, T.A. and Shelton, C. (2006) Stapedectomy in Congenital Stapes Fixation: Are Hearing Outcomes Poorer? Otolaryngology—Head and Neck Surgery, 134, 816-818. https://doi.org/10.1016/j.otohns.2005.10.063</mixed-citation></ref><ref id="scirp.88362-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Shiao, A.S., Kuo, C.L., Cheng, H.L., Wang, M.C. and Chu, C.H. (2014) Controversial Issues of Optimal Surgical Timing and Patient Selection in the Treatment Planning of Otosclerosis. European Archives of Oto-Rhino-Laryngology, 271, 1007-1014. https://doi.org/10.1007/s00405-013-2529-6</mixed-citation></ref><ref id="scirp.88362-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">House, J.W. and Cunningham, C.D. III (2010) Otosclerosis. Cummings Otolaryngology Head and Neck Surgery. Fifth Edition, 144.</mixed-citation></ref><ref id="scirp.88362-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Shabana, Y.K., Ghonim, M.R. and Pedersen, C.B. (1999) Stapedotomy: Does Prosthesis Diameter Affect Outcome? Clinical Otolaryngology and Allied Sciences, 24, 91-94. https://doi.org/10.1046/j.1365-2273.1999.00207.x</mixed-citation></ref><ref id="scirp.88362-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Portmann, D., Alcantara, M. and Vianna, M. (2007) The Length of the Piston in Otosclerosis Surgery. Revue de Laryngologie-Otologie-Rhinologie, 128, 55-58.</mixed-citation></ref><ref id="scirp.88362-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Boleas-Aguirre, M.S., Ruiz de Erenchun-Lasa, I. and Bulnes-Plano, M.D. (2015) Audiological Results after Total Ossicular Reconstruction for Stapes Fixation. European Archives of Oto-Rhino-Laryngology, 272, 3123-3130. https://doi.org/10.1007/s00405-014-3303-0</mixed-citation></ref><ref id="scirp.88362-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ataide, A.L., Bichinho, G.L. and Patruni, T.M. (2013) Audiometric Evaluation after Stapedotomy with Fisch Titanium Prosthesis. Brazilian Journal of Otorhinolaryngology, 79, 325-335. https://doi.org/10.5935/1808-8694.20130058</mixed-citation></ref><ref id="scirp.88362-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Singh, P.P. and Goyal, A. (2013) Our Experience with the Titanium Soft Clip Piston Stapedotomy. Indian Journal of Otolaryngology and Head &amp; Neck Surgery, 65, 280-282. https://doi.org/10.1007/s12070-011-0459-4</mixed-citation></ref><ref id="scirp.88362-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ahmed, S., Raza, N., Ali, L., Ullah, S. and Iqbal, S. (2006) Hearing Improvement after Stapedotomy Using Teflon Loop Prosthesis. Journal of College of Physicians and Surgeons Pakistan, 16, 659-661.</mixed-citation></ref><ref id="scirp.88362-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Dall’igna, C., Teixeira, V.N., Dall’igna, D.P. and Rosito, L.P. (2008) Results of Stapes Surgery Forotosclerosis with Two Kinds of Prosthesis in Residency Training. Brazilian Journal of Otorhinolaryngology, 74, 826-832. https://doi.org/10.1590/S0034-72992008000600004</mixed-citation></ref><ref id="scirp.88362-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Morshed, K., Siwiec, H., Szymański, M. and Golabek, W. (2003) Bone and Air Conduction after Stapedectomy. Annales Universitatis Mariae Curie-Sklodowska, 58, 33-37.</mixed-citation></ref><ref id="scirp.88362-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Skrivan, J., Cada, Z., Kluh, J., Boucek, J., Profant, O. and Betka, J. (2014) Revision Operations after Previous Stapes Surgery for Persisting Hearing Loss. Bratislavske Lekarske Listy, 115, 442-444.</mixed-citation></ref><ref id="scirp.88362-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Massey, B.L., Kennedy, R.J. and Shelton, C. (2005) Stapedectomy Outcomes: Titanium versus Teflon Wire Prosthesis. Laryngoscope, 115, 249-252. https://doi.org/10.1097/01.mlg.0000154727.85539.76</mixed-citation></ref><ref id="scirp.88362-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Vishwakarma, R., Patadia, S., Goswami, P., Patel, K. and Darji, D. (2014) Teflon vs. Titanium Prostheses in Stapes Surgery. Journal of Otolaryngology, 4, 53-63.</mixed-citation></ref><ref id="scirp.88362-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Causse, J.R., Causse, J.B., Uriel, J., Berges, J., Shambaugh, G.E. and Bretlau, P. (1993) Sodium Fluoride Therapy. American Journal of Otolaryngology, 14, 482-490.</mixed-citation></ref></ref-list></back></article>